ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SKIN Integumen Plc

28.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Integumen Plc LSE:SKIN London Ordinary Share GB00BMGWZY29 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 28.00 28.00 29.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Deepverge PLC Result of Meeting (3283G)

14/11/2022 12:16pm

UK Regulatory


Integumen (LSE:SKIN)
Historical Stock Chart


From Apr 2022 to Apr 2024

Click Here for more Integumen Charts.

TIDMDVRG

RNS Number : 3283G

Deepverge PLC

14 November 2022

14 November 2022

DeepVerge PLC

("DeepVerge" or "the Company")

Result of General Meeting

Result of General Meeting

Following today's General Meeting ("GM") DeepVerge PLC is pleased to announce that both resolutions set out in the Notice of GM were approved by Shareholders.

The results of the voting for each resolution were as follows:

 
 Resolution                              For            % For      Against     % Against   Withheld 
 
        1. To authorise the directors 
        of the Company to allot 
        shares in the capital of 
        the Company in accordance 
        with section 551 of the 
        Companies Act 2006.                95,611,547     99.42%     552,944     0.58%       79,467 
                                        -------------  ---------  ----------  ----------  --------- 
 
        2. To authorise the directors 
        of the Company to allot 
        equity securities other 
        than in accordance with 
        statutory pre-emption rights 
        that would otherwise apply 
        pursuant to section 561 
        of the Companies Act 2006          95,284,770     99.07%     897,630     0.93%       61,558 
                                        -------------  ---------  ----------  ----------  --------- 
 

As at the date of the GM, the number of issued ordinary shares of the Company was 252,662,334 shares, which was the total number of shares entitling the holders to attend and vote for or against all resolutions. In accordance with the Company's Articles of Association, on a poll every member has one vote for every share held. Votes withheld are not votes in law and have not been counted in the calculation of the proportion of vote "for" or "against" a resolution. Proxy appointments which gave discretion to the Chairman have been included in the "for" total.

Second Admission will become effective and dealings will commence in the 135,000,000 Second Tranche Placing Shares by 8.00 a.m. on 15 November 2022.

Third Admission will become effective and dealings will commence in the 303,784,044 Third Tranche Placing Shares, the 28,360,000 Subscription Shares and 40,750,000 Broker Offer Shares (totalling 372,794,044 new Ordinary Shares) by 8.00 a.m. on 16 November 2022.

March 2022 Loan

As set out in the notification of 27 October 2022, the Company expects to repay all amounts due under the March 2022 Loan facility with Riverfort within the next few days out of the proceeds of the Fundraising.

Terms and definitions in this notification are as defined in the notification of 27 October 2022.

For further information, please contact:

Enquiries:

 
                            Nigel Burton, 
 DeepVerge plc               Interim Chief Executive    +44 7785 234447 
 
 SPARK Advisory Partners 
  Limited 
  (Nominated Adviser)       Neil Baldwin                +44 (0) 113 370 8974 
 
 Turner Pope Investments 
  (TPI) Limited             Andy Thacker/James 
  (Broker)                   Pope                       +44 (0) 20 3657 0050 
 

Market Abuse Regulation (MAR) Disclosure

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ROMBIBTTMTBBBIT

(END) Dow Jones Newswires

November 14, 2022 07:16 ET (12:16 GMT)

1 Year Integumen Chart

1 Year Integumen Chart

1 Month Integumen Chart

1 Month Integumen Chart

Your Recent History

Delayed Upgrade Clock